PCVX
(NASDAQ)Vaxcyte, Inc.
$60.36-- (--)
Loading... - Market loading
Vaxcyte (PCVX) Stock Price & Financial Analysis
Vaxcyte Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Day's Range$59.22 - $61.03
52-Week High$65.00
52-Week Low$30.81
Open$60.25
Volume1.02M
Average Volume (3M)980.38K
Market Cap8.53B
Shares Outstanding139.51M
Price to Book (P/B)2.85
EV/EBITDA-8.56
50-Day MA$58.26
200-Day MA$54.12
52-Week Change86.24%
Annual Dividend$0.00
Dividend Yield0.00%
Day's Range$59.22 - $61.03
52-Week High$65.00
52-Week Low$30.81
Open$60.25
Volume1.02M
Average Volume (3M)980.38K
Market Cap8.53B
Shares Outstanding139.51M
Price to Book (P/B)2.85
EV/EBITDA-8.56
50-Day MA$58.26
200-Day MA$54.12
52-Week Change86.24%
Annual Dividend$0.00
Dividend Yield0.00%
Frequently Asked Questions About Vaxcyte
What is the current stock price for PCVX?
As of the latest trading session, PCVX stock trades at $60.36. The 52-week range is $30.81–$65.00, with a day range of $59.22–$61.03.
What is the P/E ratio for PCVX?
The P/E ratio (Price-to-Earnings) for PCVX is shown in the Key Statistics section. This valuation metric helps compare Vaxcyte, Inc. to industry peers.
Does PCVX pay dividends?
Vaxcyte does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for PCVX?
Based on 3 analysts, the consensus for PCVX is Buy.
What is the market cap of PCVX?
Vaxcyte's market capitalization is $8.42B, classifying it as a mid-cap company. Vaxcyte operates in the Healthcare sector within the Biotechnology industry.